A human cadaver model for determination of pathologic fracture threshold resulting from tumorous destruction of the vertebral body

Spine

Volumn 23, Issue 11, 1998, Pages 1209-1214

  Dimar II, John R ^a,b   Voor, Michael J ^a   Zhang, Yong Ming ^a   Glassman, Steven D ^a  

^a University of Louisville School of Medicine   (United States)

^b Spine Institute   (United States)

Author keywords

Biomechanics; Bone mineral density; Metastatic involvement; Pathologic spinal fracture; Prophylactic stabilization

Indexed keywords

ARTICLE; BIOMECHANICS; BONE DENSITY; BONE METASTASIS; BONE STRENGTH; CADAVER; HUMAN; HUMAN TISSUE; MODEL; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; PROPHYLAXIS; SPINE FRACTURE; SPINE STABILIZATION;

AGED; AGED, 80 AND OVER; BONE DENSITY; CADAVER; COMPRESSIVE STRENGTH; FRACTURES, SPONTANEOUS; HUMANS; MIDDLE AGED; MODELS, ANATOMIC; SPINAL FRACTURES; SPINAL NEOPLASMS; THORACIC VERTEBRAE;

EID: 0032100799     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-199806010-00006     Document Type: Article

References (18)

1. An HS, Andreshak TG, Nguyen C, Williams A, Daniels D. Can we distinguish between benign vs. malignant compression fractures of the spine by magnetic resonance imaging? Spine 1995;20:1776-82.
2. Bauer H, Wedin R. Survival after surgery for spinal and extremity surgery. Acta Orthop Scand 1995;66:143-6.
3. Boland PJ, Lane JM, Sundarsan N. Metastatic disease of the spine. Clin Orthop 1982;169:95-102.
4. Boring C, Squires T, Tony T. Cancer statistics. Cancer J Clin 1993;43:7-26.
5. Brinkmann R, Biggerman M, Hilweg D. Prediction of the compressive strength of human lumbar vertebrae. Spine 1989; 14:606-10.
6. DeWald RL, Bridwell KH, Prodromas C, Rodts MF. Reconstructive spinal surgery as palliation for metastatic malignancy of the spine. Spine 1985;10:21-6.
7. Fidler M. Anterior decompression and stabilization of metastatic spine fractures. J Bone Joint Surg [Br] 1986;68:83-9.
8. Harrington KD. Anterior decompression and stabilization of the spine as a treatment for vertebral collapse and spinal cord compression from metastatic malignancy. Clin Orthop 1988;233:177-97.
9. Harrington KD. The use of methyl methacrylate for vertebral body replacement and anterior stabilization of pathological fracture-dislocations of the spine due to metastatic malignant disease. J Bone Joint Surg [Am] 1981;63:36-46.
10. Henzel JH, Mohr GC, vonGierke HE. Reappraisal of biodynamic implications of human ejections. Aerospace Med 1968;39:231-40.
11. Hipp JA, Springfield DS, Hayes WC. Predicting pathological fracture risk in the management of metastatic bone defects. CORR 1995;312:120-35.
12. McGowan DP, Hipp JA, Takeuchi T, White AA, Hayes WC. Strength reductions from trabecular destruction within thoracic vertebrae. J Spinal Disord 1993;6:130-6.
13. McGuire RA, Freeland A. Pathological spine fractures. Orthopaedics 1992;15:644-6.
14. McLain RF, Weinstein JN. Tumors of the spine. Semin Spine Surg 1990;2:157-80.
15. Nachemson A. Towards a better understanding of back pain: A review of the mechanics of the lumbar disc. Rheumatol Rehabil 1975,14:129-43.
16. Onuigbo, WI. Recognition and treatment of pathological fractures in the nineteenth century. Surgery 1975;77:553-6.
17. Weinstein JN. Differential diagnosis and surgical treatment of pathological spine fractures. American Academy of Orthopaedic Surgeons Instructional Course Lectures 1992;41: 301-15.
18. Windhagen H, Hipp JA, Lipson SJ, Hayes WC. QCT explains over 90% in variance of failure load in human vertebrae with simulated metastatic defects. Presented at the annual meeting of the Orthopaedic Research Society, Orlando, Florida, February 13, 1995.